Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.

Analyst Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report) and decreased the price target to $651.00 ...

McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...

The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.

McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

“Federal contractors must not engage in discriminatory hiring practices, it is the responsibility of the employer to ensure ...

In terms of liquidity and interest, the mean open interest for McKesson options trades today is 166.17 with a total volume of ...